Paeoniflorin ameliorates cognitive impairment in Parkinson’s disease via JNK/p53 signaling

Paeoniflorin (PF) has numerous benefits, including anti-inflammatory and anti-apoptosis effects. However, it is not clear if it has neuroprotective effects against cognitive impairment (CI) in Parkinson’s disease (PD). Through network pharmacology, we identified probable targets as well as signal pa...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Zhu-qing, Huan, Peng-fei, Wang, Li, He, Jian-cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042992/
https://www.ncbi.nlm.nih.gov/pubmed/35230626
http://dx.doi.org/10.1007/s11011-022-00937-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042992/
https://www.ncbi.nlm.nih.gov/pubmed/35230626
http://dx.doi.org/10.1007/s11011-022-00937-2

Ejemplares similares